EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Annals of Pharmacotherapy


 

Status
active
Subject

Source type
Journal
ISBN ISSN
1060-0280
E ISSN
1542-6270
First volume
1
Last volume
42+
Homepage
Description
Now in its 42nd year, The Annals is an independent, peer-reviewed medical journal that advances pharmacotherapy throughout the world by publishing evidence-based articles on practice, research, and education. The Annals provides an independent forum for the discussion and analysis of professional issues in pharmacotherapy. To fulfill its mission, The Annals will:
  • publish research reports, reviews, commentaries, case reports, and other articles that are of high quality, unique, and timely and that will advance patient care and clinical pharmacy practice.
  • provide service that is personal, professional, and prompt to authors, reviewers, and subscribers, surpassing their expectations and building ongoing relationships.
  • maintain an editorial board and referee base of skilled, dedicated clinicians, researchers, and educators with collective expertise in all areas of pharmacy.
  • keep abreast of the latest developments in publishing and information technology, adopting those deemed most likely to enhance the journal’s content and services.
 
With this focus, The Annals of Pharmacotherapy will continually strive to improve clinical practice and patient care worldwide.


Related links:









Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )